Dysbiosis in aspirin‐exacerbated respiratory disease.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      AERD = aspirin-exacerbated respiratory disease; OTU = operational taxonomic unit gl DISCUSSION AERD microbiomes reflect dysbiosis with loss of diversity, particularly I Corynebacterium i and other commensal bacteria, and high relative abundance of pathogenic species. Aspirin-exacerbated respiratory disease, asthma, chronic rhinosinusitis, dysbiosis, microbiome, nasal polyposis, nasal polyps Keywords: aspirin-exacerbated respiratory disease; asthma; chronic rhinosinusitis; dysbiosis; microbiome; nasal polyposis; nasal polyps EN aspirin-exacerbated respiratory disease asthma chronic rhinosinusitis dysbiosis microbiome nasal polyposis nasal polyps 1116 1120 5 06/30/21 20210701 NES 210701 Aspirin-exacerbated respiratory disease (AERD) is a distinct subtype of severe chronic rhinosinusitis (CRS) characterized by nasal polyposis, difficult-to-treat asthma, and adverse reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). [Extracted from the article]
    • Abstract:
      Copyright of International Forum of Allergy & Rhinology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)